Skip to content

Long-term clinical course and extracerebellar manifestations of hereditary spinocerebellar degeneration.

Aug 2026 · Acta Neurologica Belgica · 0 citations · 23 references
Medicine

TL;DR

Brain perfusion analysis revealed that reduced blood flow to the precentral gyrus at baseline was associated with the manifestation of pyramidal signs at the endpoint, and greater increases in the ICARS scores over time and an earlier onset of wheelchair dependence.

View source

Similar papers

Open access Aug 2026

Neurological disease progression in adults with ataxia-telangiectasia: a longitudinal study

Although AT subtypes differ substantially in childhood and adolescence, neurological decline converges to a similar pace in adulthood, irrespective of subtype or genotype, which inform counselling, prognostication, and the design of interventional trials, including mutation-specific therapies.

A. Hensiek, L. Bottolo, M. Tiet et al. · 0 citations
Open access Oct 2026

Prevalence and Spectrum of Non-Motor Symptoms in Patients of Spinocerebellar Ataxias in Kashmiri Population

Background: Spinocerebellar ataxias (SCAs) are progressive neurodegenerative disorders increasingly recognized to have substantial non-motor manifestations. Data regarding these symptoms in the Kashmiri population remain limited. Objective: To assess the prevalence and pattern of non-motor symptoms among genetically co...

B. Sanaie, S. Tak, Tanveer Hassan et al. · 0 citations
Open access Aug 2026

Clinical and genetic landscape of neuronopathic gaucher disease in Ukraine: hepatosplenomegaly and diagnostic delay

Neuronopathic Gaucher disease (GD types II and III) represents rare and severe phenotypes of glucocerebrosidase deficiency, characterized by neurological involvement and variable systemic manifestations. Data on clinical presentation and genotype–phenotype patterns in Eastern European populations remain limited. We con...

N. Samonenko, N. Olkhovych, O. Okhotnikova et al. · 0 citations
Open access Sep 2026

Early Recognition of Patients with Neuronopathic Forms of Mucopolysaccharidosis Type II in Clinical Practice

Background: Mucopolysaccharidosis type II (MPS II) is a progressive, rare, X-linked inherited disease with multi-organ involvement and a restricted life expectancy. The disease has two main forms: neuronopathic (severe) and non-neuronopathic (attenuated). Aim: To compare the two main forms of MPS II to identify signs f...

Nataliya V. Buchinskaia, E. Zakharova, Anastasia O. Vechkasova et al. · 0 citations
Open access Aug 2026

Clinical and Genetic Spectrum of ATP1A3-Related Disorders

The results highlight the need for a unified diagnostic framework for ATP1A3-related disorders and demonstrate the feasibility and scientific value of coordinated rare disease research in resource-limited settings.

Victor Rebelo Procaci, Raphael Pinheiro Camurugy da Hora, Anna Maria Gomes et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.